NCT03410394 Registry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)
| NCT ID | NCT03410394 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Central Hospital, Nancy, France |
| Condition | Endocrine Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2015-01-01 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2015-01-01 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This registry aims to collect informations about patients with endocrine tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube) who undergo endocrine surgical procedures. This registry is part of the Eurocrine Project.
Eligibility Criteria
Inclusion Criteria: * patients who undergo surgical procedures for endocrine tumors at the University Nancy Brabois Hospital Exclusion Criteria: * unable to receive clear information * refusal to sign the consent form
Contact & Investigator
laurent Brunaud, MD, PhD
✉ l.brunaud@chru-nancy.frlaurent Brunaud
PRINCIPAL INVESTIGATOR
University of Lorraine
Frequently Asked Questions
Who can join the NCT03410394 clinical trial?
This trial is open to participants of all sexes, studying Endocrine Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03410394 currently recruiting?
Yes, NCT03410394 is actively recruiting participants. Contact the research team at l.brunaud@chru-nancy.fr for enrollment information.
Where is the NCT03410394 trial being conducted?
This trial is being conducted at Vandœuvre-lès-Nancy, France.
Who is sponsoring the NCT03410394 clinical trial?
NCT03410394 is sponsored by Central Hospital, Nancy, France. The principal investigator is laurent Brunaud at University of Lorraine. The trial plans to enroll 3,000 participants.